What Feldene Gel Treats: Main Uses and Benefits

Feldene Gel (Piroxicam) is indicated for use in therapeutic domains involving localized pain and inflammatory states. The formulation is applied when short-term symptomatic assistance is needed to help ease symptoms associated with musculoskeletal issues.

The gel is commonly used across conditions presenting with episodic or fluctuating manifestations, including the symptomatic management of Osteoarthritis, as well as during acute episodes involving soft tissue damage like sprains, strains, contusions, and localized inflammatory conditions such as tendonitis and periarthritis.

The core purpose of the topical application is aimed at easing localized discomfort and symptoms related to inflammatory states. This approach may provide support to patients, such as:

“... supporting them to cope more steadily with symptom fluctuations and assisting with maintaining functional stability during symptomatic phases.”

This supportive relief contributes to easing the overall symptom load and is intended to support day-to-day comfort during symptomatic periods.

Quick Fact	Relief for Musculoskeletal Pain
Primary Symptoms	Localized pain, swelling, and stiffness
Acute Contexts	Sprains, strains, and contusions
Chronic Contexts	Osteoarthritis of peripheral joints
Patient Benefit	Supports functional stability and eases symptom burden

Who Can and Cannot Use Feldene Gel? (Piroxicam Gel)

Official regulatory guidelines define specific populations and conditions where the use of Feldene Gel is either allowed, restricted, or strictly contraindicated.

Contraindications (Must NOT Use)

Condition / Population	Restriction Type	Reason Basis
Hypersensitivity	Absolute Contraindication	Known allergy to piroxicam or any ingredient, or history of allergic reactions to aspirin or other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs).
Late Pregnancy	Absolute Contraindication	Must not be used in the last 3 months of pregnancy (after 24 weeks' gestation) due to risk to the fetus.
Pediatric Use	Absolute Contraindication	Not for use in children under 12 years of age; safety and efficacy are not established.
Application Site	Absolute Contraindication	Must not be applied to broken, damaged, infected skin, open lesions, or mucosal surfaces (e.g., eyes, mouth).

Use Restrictions and Cautions

Use is not recommended for women who are breastfeeding or those attempting to conceive. The gel should be used with extreme caution in elderly patients and in individuals with a history of peptic ulceration, GI bleeding, severe renal impairment, or hepatic impairment.

Feldene Gel Interactions with other medicines and products

Feldene Gel contains piroxicam, a Nonsteroidal Anti-inflammatory Drug (NSAID). Since only low levels of piroxicam from the topical gel are typically absorbed into the bloodstream with normal use, the potential for drug-to-drug interactions is generally considered lower than with oral NSAIDs. However, caution is still necessary, and you should inform your doctor or pharmacist about all other medicines you are taking.

Combination with Other NSAIDs

Avoid using Feldene Gel at the same time as other NSAIDs, including over-the-counter products like aspirin or ibuprofen, or other topical NSAID preparations. This increases the risk of side effects, particularly those affecting the digestive tract, even with topical application.

Other Potential Interactions

Although the risk is low, tell your healthcare provider if you are taking any of the following medicines, as their effects could theoretically be altered or the risk of adverse effects increased, especially with excessive use of the gel or if you have pre-existing health conditions:

• Anticoagulants (e.g., warfarin): Increased risk of bleeding.
• Lithium (used for certain mental health disorders): May lead to increased lithium blood levels.
• Methotrexate (used for arthritis and some cancers): May lead to decreased elimination of methotrexate.
• Diuretics (water pills) and certain blood pressure medications (e.g., ACE inhibitors): Piroxicam may reduce their therapeutic effects and may increase the risk of kidney problems.
• Corticosteroids (e.g., prednisone): Increased risk of gastrointestinal side effects.

Feldene Gel delivers piroxicam to the local cutaneous and subcutaneous tissues. The drug's mechanism is defined by its action as a non-selective inhibitor of cyclooxygenase (COX) enzymes, specifically COX-1 (EC 1.14.99.1) and COX-2 (EC 1.14.99.1).

The COX enzymes catalyze the conversion of arachidonic acid into prostaglandin H2, a key intermediate in the biosynthesis of prostanoids, including prostaglandins and thromboxanes. Piroxicam reversibly binds to and obstructs the catalytic sites of COX-1 and COX-2.

This molecular interaction leads to a downstream cascade: the cellular production of prostaglandins, which are lipid signaling molecules involved in vasodilation and increased vascular permeability, is attenuated. Additionally, piroxicam may modulate other cellular processes, including the inhibition of lysosomal membrane rupture and the attenuation of neutrophil function, thereby impacting the release of pro-inflammatory mediators. The overall system-level physiological consequence is the localized modulation of inflammatory processes within the targeted tissues.

How to Use Feldene Gel (Piroxicam 0.5% w/w Gel)

Feldene Gel is for external use and is applied directly to the skin.

Administration Details

Category	Official Instructions
Route of Administration	External use (Cutaneous application)
Standard Adult Dose	A strip of gel approximately 3 cm (1 1/4 inches) in length, corresponding to 1 gram of gel
Frequency	Apply the measured dose to the affected area two to four times daily
Duration Review	Treatment should be reviewed at regular intervals. Therapy must be discontinued if no benefit is seen, and should generally not exceed four weeks without review

Procedural Steps and Restrictions

• Preparation: Break the tube's seal by reversing the cap and screwing it down.
• Application: Apply the specified amount of gel and gently rub it into the skin until the gel disappears/is absorbed (leaving no residual material). If the gel is not fully rubbed in, temporary staining of the skin or clothing may occur.
• Post-Application: Wash hands well after each application, unless the hands themselves are the area being treated.
• Skin Integrity: Do not apply the gel to open skin lesions, wounds, infections, or mucous membranes (eyes, nose, mouth).
• Dressings: Occlusive dressings (airtight bandages) must not be used over the treated area.
• Sunlight: Protect the treated area from strong sunlight.

Age-Specific Instructions

• Elderly Patients: The lowest dose compatible with adequate clinical control should be used, as this population is more susceptible to potential adverse events.
• Children (Paediatric Population): Use is not recommended in children due to the absence of established experience regarding its safety and efficacy.

Research Evidence / Overview of Studies for Feldene Gel

Evidence for Use in Osteoarthritis of Peripheral Joints

Research was studied for use in patients with conditions characterized by fluctuating or episodic manifestations of osteoarthritis (OA), particularly in joints closer to the skin surface. The main research approach has utilized short-term Randomized Controlled Trials (RCTs), where patients was observed in over limited periods, typically between two and four weeks. These trials focused on outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level.

Studies monitored the populations, and findings describe patterns observed in the studies regarding patient-reported outcomes describing perceived discomfort. Since the follow-up durations were limited, these findings provide insight primarily into short-term symptom changes during periods of heightened symptom activity. Long-term effects are not fully established, and evidence quality varies across studies.

---

Evidence for Acute Soft Tissue Injuries

Piroxicam gel was evaluated in research settings involving conditions associated with acute or disruptive episodes, such as sprains, strains, and tendinitis. Research used very short-term, double-blind, placebo-controlled trials. These studies focused on outcomes describing episodic or acute changes, such as a patient's self-assessment of "clinical success" or monitoring how symptoms evolved over defined time intervals, often around 7 to 14 days.

The evidence level for this context appears to be High, based on the number of available RCTs and systematic reviews. The tendency of conditions associated with acute episodes to resolve on their own means that only well-designed studies can isolate patterns related to the treatment. Comparative evidence is lacking for piroxicam specifically against every single other individual topical pain gel in head-to-head trials.

---

Research Gaps and Areas of Uncertainty

Data for certain groups remain insufficient. Research specifically examining patient-reported experiences and outcomes in older adults who may have co-existing health issues is limited. Follow-up durations were limited in many primary studies, and these factors mean that findings describe group patterns, not personal outcomes.

Key Studies & References Management of osteoarthritis - NICE Guideline NG226 (Visual Summary)

Common questions about Feldene Gel (FAQ)

---

Q: Does this medication make you sleepy or affect driving?

A: Official regulatory documents indicate that this medication may cause drowsiness, dizziness, or affect judgment, thinking, and motor skills. Regulatory warnings mention that individuals should exercise caution regarding driving or operating hazardous machinery, as it is unknown how the medication will affect them.

---

Q: Can I drink alcohol while taking this medicine?

A: Regulatory safety information states that this medicine may increase the effects of alcohol and other substances that affect the central nervous system (CNS). Because alcohol may worsen certain side effects, the regulatory documents suggest consulting a healthcare professional regarding the use of alcoholic beverages while taking this medication.

---

Q: Is this medication safe to use during pregnancy or while breastfeeding?

A: Official product information on pregnancy states that the potential benefit must justify the potential risk to the fetus, as the safety of use has not been definitively established in pregnant women. For nursing mothers, use with caution is noted because the medicine has been detected in the milk of lactating animals in studies.

---

Q: Can children 2 years old use it?

A: The medication is generally not approved for use in pediatric patients (children and adolescents). Regulatory warnings for this class of medicine also note the need to consider the potential for serious side effects in this population, which is why it is not typically prescribed.

---

Q: Where should I store this medicine?

A: According to the official product information for storage and handling, the drug is to be stored at controlled room temperature. This is typically defined as being between 20 C to 25 C (68 F to 77 F).

---

Q: What is the correct way to take this medicine (with food or empty stomach)?

A: The regulatory documents mention that specific formulations may be recommended to be taken at a consistent time, such as in the late evening or at bedtime. It also notes that taking it with food can affect drug absorption, and some product labels specify administration on an empty stomach.

How to Store and Dispose of Feldene Gel (Piroxicam Gel)

Feldene Gel must be stored and disposed of according to official regulatory instructions to maintain product stability and ensure safety.

---

Storage Requirements

Condition	Requirement (Official Regulatory Standard)
Temperature	Store below 25 C or 30 C and away from excess heat [room temperature].
Environment	Protect from dampness; Do not store near a sink or in a bathroom.
Child Safety	Keep out of the sight and reach of children (mandatory).
Container	Keep the tube in its original container and ensure the cap is tightly closed after each use.
Stability	The gel must be used within six months of first opening, provided it is before the printed expiration date.

---

Disposal Instructions

Any unused or expired Feldene Gel must be disposed of in accordance with local regulatory requirements. Patients should ask a pharmacist for the proper method of disposal, such as using a drug take-back option. The product must not be flushed down the toilet or poured into wastewater systems.